Lipopolysaccharide (LPS) is a specific ligand of Toll‐like receptor 4 (TLR4) and is known to regress tumors by regulating the cytokine generation and recruitment of immune cells at the tumor site [10, 11, 12, 13, 14]. Here, TLR4 is linked to neoplasm.